Market News AIOpen the app

IMMX stock news · Immix Biopharma

Stories about Immix Biopharma (IMMX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IMMX

Follow Immix Biopharma (IMMX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IMMX
Free on the App Store and Google Play, or on the web.
  1. Nov 13, 2026, 9:19 AM ET · Market

    Immix Biopharma shared its Q3 2026 results, showing $340.9 million in cash and $15.9 million in expenses.

    Good or bad for IMMX?
  2. Nov 12, 2026, 4:48 PM ET · Results

    Immix Biopharma, Inc.: Results of Operations and Financial Condition (IMMX)

    Good for IMMX

    Immix reported an 89% complete response rate across 45 patients and $340.9 million in cash, expected to last into mid-2028. This update favors the company.